We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
216 hedge funds and large institutions have $2.46B invested in Revance Therapeutics, Inc. in 2023 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 63 increasing their positions, 74 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
152% more call options, than puts
Call options by funds: $57.2M | Put options by funds: $22.6M
100% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 25
81% more capital invested
Capital invested by funds: $1.36B → $2.46B (+$1.1B)
12% more funds holding
Funds holding: 193 → 216 (+23)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 74
Holders
216
Holders Change
+23
Holders Change %
+11.92%
% of All Funds
3.44%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
50
Increased
63
Reduced
74
Closed
25
Calls
$57.2M
Puts
$22.6M
Net Calls
+$34.5M
Net Calls Change
-$63.9M
Top Buyers
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$60.7M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$59M |
| 3 |
D.E. Shaw & Co
New York
|
+$29.7M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$18.6M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$17.7M |
Top Sellers
| 1 |
BlackRock
New York
|
-$29.1M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$21.2M |
| 3 |
PA
Perceptive Advisors
New York
|
-$13.5M |
| 4 |
Jennison Associates
New York
|
-$12.2M |
| 5 |
Millennium Management
New York
|
-$12M |
